Roche Reports H1 2026 Revenue Of CHF 30.4B, Up 6% At CER But Down 2% In CHF, As Core EPS Rises 9% At CER To CHF 10.85 From CHF 11.08
Share
Why It Matters
Roche made more money in the first half of 2026 when you account for currency changes, even though it looks smaller in Swiss francs because exchange rates shifted. The company's profit per share grew, which shows they're running more efficiently.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.